These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Characterization of the histamine receptors in the guinea-pig lung: evidence for relaxant histamine H3 receptors in the trachea. Cardell LO; Edvinsson L Br J Pharmacol; 1994 Feb; 111(2):445-54. PubMed ID: 7911715 [TBL] [Abstract][Full Text] [Related]
50. Serotonergic facilitation of acetylcholine release in vivo from rat dorsal hippocampus via serotonin 5-HT3 receptors. Consolo S; Bertorelli R; Russi G; Zambelli M; Ladinsky H J Neurochem; 1994 Jun; 62(6):2254-61. PubMed ID: 8189232 [TBL] [Abstract][Full Text] [Related]
51. Serotonin and psychiatric disorders. A key to new therapeutic approaches. Costall B; Naylor RJ Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395 [TBL] [Abstract][Full Text] [Related]
52. Ciproxifan and chemically related compounds are highly potent and selective histamine H3-receptor antagonists. Kathmann M; Schlicker E; Marr I; Werthwein S; Stark H; Schunack W Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):623-7. PubMed ID: 9879720 [TBL] [Abstract][Full Text] [Related]
53. Clozapine's antipsychotic effects do not depend on blockade of 5-HT3 receptors. Squires RF; Saederup E Neurochem Res; 1999 May; 24(5):659-67. PubMed ID: 10344595 [TBL] [Abstract][Full Text] [Related]
54. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice. Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508 [TBL] [Abstract][Full Text] [Related]
55. Therapeutic approach of histamine H3 receptors in obesity. Masaki T; Yoshimatsu H Recent Pat CNS Drug Discov; 2007 Nov; 2(3):238-40. PubMed ID: 18221234 [TBL] [Abstract][Full Text] [Related]
56. 5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis. Aapro MS Drugs; 1991 Oct; 42(4):551-68. PubMed ID: 1723361 [TBL] [Abstract][Full Text] [Related]
57. [The histamine H3 receptor: a new target for the treatment of arousal and cognitive disorders]. Arrang JM Ann Pharm Fr; 2007 Jul; 65(4):275-84. PubMed ID: 17652997 [TBL] [Abstract][Full Text] [Related]
58. 5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release. Maura G; Andrioli GC; Cavazzani P; Raiteri M J Neurochem; 1992 Jun; 58(6):2334-7. PubMed ID: 1533419 [TBL] [Abstract][Full Text] [Related]
59. Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia. Giovannini MG; Bartolini L; Bacciottini L; Greco L; Blandina P Behav Brain Res; 1999 Oct; 104(1-2):147-55. PubMed ID: 11125734 [TBL] [Abstract][Full Text] [Related]
60. Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs. Zhang M; Ballard ME; Pan L; Roberts S; Faghih R; Cowart M; Esbenshade TA; Fox GB; Decker MW; Hancock AA; Rueter LE Brain Res; 2005 May; 1045(1-2):142-9. PubMed ID: 15910772 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]